Stocks
Iovance Biotherapeutics (IOVA) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.32 | 1.02 | 0.48 | 0.76 | 0.70 | 0.82 | |||
| Changes by years, y/y, % | -41% | -22% | -53% | +58% | -8% | -20.7% | |||
Iovance Biotherapeutics. Debt/EBITDA
Iovance Biotherapeutics. Debt/EBITDA, changes, %
Iovance Biotherapeutics (IOVA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| Debt/EBITDA | 0.69 | 0.68 | 0.70 | 0.83 | 0.96 | 0.82 | ||
| Changes by years, y/y, % | -12% | -17% | -8% | -5% | +38% | |||
| Changes by quarters, q/q, % | -20% | -2% | +2% | +19% | +16% | |||
